Lung adenocarcinoma genetic test usually needs to be done 1-3 times, depending on whether the drug is resistant or not.
Lung adenocarcinoma genetic test is an examination program that must be conducted before targeted drug therapy, which includes gene mutation, gene rearrangement and gene amplification, etc. According to the examination result, it is possible to determine whether targeted therapy can be conducted and what are the suitable targeted drugs, which is usually required only once, but it depends on the patient’s condition.
If the effect of targeted drug therapy is not good or drug resistance occurs, it is necessary to carry out another examination on the basis of the original, so as to determine the follow-up of the appropriate therapeutic drugs and treatment programs to enhance the therapeutic effect.